These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7504707)

  • 1. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory role of CD40 in human B cell differentiation.
    Splawski JB; Fu SM; Lipsky PE
    J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
    Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
    Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
    Pellat-Deceunynck C; Amiot M; Robillard N; Wijdenes J; Bataille R
    Cancer Res; 1996 Apr; 56(8):1909-16. PubMed ID: 8620513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
    Kwekkeboom J; De Boer M; Tager JM; De Groot C
    Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble forms of CD40 inhibit biologic responses of human B cells.
    Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
    J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
    Larson AW; LeBien TW
    J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro.
    Tong AW; Zhang BQ; Mues G; Solano M; Hanson T; Stone MJ
    Blood; 1994 Nov; 84(9):3026-33. PubMed ID: 7524765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD74 is expressed by multiple myeloma and is a promising target for therapy.
    Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
    Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
    Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
    J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
    Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
    Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.
    Renard N; Duvert V; Blanchard D; Banchereau J; Saeland S
    J Immunol; 1994 Feb; 152(4):1693-701. PubMed ID: 7509827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis.
    Björck P; Paulie S
    Immunology; 1993 Feb; 78(2):218-25. PubMed ID: 7682536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40.
    Diaz-Sanchez D; Chegini S; Zhang K; Saxon A
    J Immunol; 1994 Jul; 153(1):10-20. PubMed ID: 7515920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 autocrine growth system in human multiple myeloma.
    Nagata K; Tanaka Y; Oda S; Yamashita U; Eto S
    Jpn J Clin Oncol; 1991 Feb; 21(1):22-9. PubMed ID: 2067118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
    Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
    Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.